Liens UNIL

FR EN

Unisciences

Vous êtes ici: UNIL > Unisciences

Recherche
- Recherche
- Afficher les données
  de à

Service de dermatologie

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil

1505 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | ...

Sous presse

Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2.

Blanchard G., Atallah I., Blanchard M., Fehrenbacher B., Schaller M., Riccio O., Ballerini C., Candotti F., Guenova E. The British journal of dermatology. Peer-reviewed.

[DOI][Pmid][serval:BIB_FCE7997FD1E1]

ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Cerminara S.E., Cvijetic I., Huber S., Müller S., Kostner L., Goessinger E.V., Narainsing J., Dutilh G., Heidemeyer K., Yawalkar N. et al. Journal of the European Academy of Dermatology and Venereology. Peer-reviewed.

[DOI][Pmid][serval:BIB_2627DC6163D3]

Line-field confocal optical coherence tomography and the diagnosis of cutaneous mastocytoma and juvenile xanthogranuloma.

Del Río-Sancho S., Christen-Zaech S. International journal of dermatology. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_BC374FAE2737]

Comparing Line-Field Confocal Optical Coherence Tomography and Reflectance Confocal Microscopy on the In Vivo Healing Process of Lesions Induced by Fractional Photothermolysis.

Del Río-Sancho S., Christen-Zaech S., Alvarez Martinez D., Pünchera J., Merat R., Laubach H.J. Lasers in surgery and medicine. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FD32C0EF49B8]

Single-centre experience with tralokinumab in dupilumab-experienced and naïve patients with atopic dermatitis.

Fossati C., Guenova E., Conrad C., Gilliet M., Seremet T. Journal of the European Academy of Dermatology and Venereology. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_EFC6FDA7CFE4]

Maintenance therapy for CTCL: importance for prevention of disease progression.

Gordon E.R., Trager M.H., Kwinta B.D., Stonesifer C.J., Lee K.J., Adeuyan O., Lapolla B.A., Akilov O.E., Enz P.A., Guenova E. et al. Leukemia & lymphoma. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D7743F1FF0D8]

A European Roundtable "Addressing Under-Prioritized Skin Diseases: Policy Responses to High-Burden Conditions", February 6, 2024.

Mammadov Y., Austin J., Shipowick T., Veldman K., Eming S., Szegedi A., Sprecher E., Conrad C. The Journal of investigative dermatology. Peer-reviewed.

[DOI][Pmid][serval:BIB_626E383E3A1F]

Autochthonous Trichophyton rubrum terbinafine resistance in France: Assessment of antifungal susceptibility tests.

Moreno-Sabater A., Cordier C., Normand A.C., Bidaud A.L., Cremer G., Bouchara J.P., Huguenin A., Imbert S., Challende I., Brin C. et al. Clinical microbiology and infection. Peer-reviewed.

[DOI][Pmid][serval:BIB_4E7A4F9451A9]

Neonatal Linear Immunoglobulin A Bullous Dermatosis: A Critical Case Recovering after Prompt Recognition, Intensive Management, and Breastfeeding Interruption - A Case Report.

Papasavva D., Dosso L., Morren M.A., Fontao L., Bruschi L., Gorostidi F., Ferry T., Guenova E., Fischer Fumeaux C.J., Joye S. Neonatology. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_701D6B438C54]

Keratinocytes present Staphylococcus aureus enterotoxins and promote malignant and non-malignant T cell proliferation in cutaneous T cell lymphoma.

Zeng Z., Vadivel C.K., Gluud M., Namini MRJ, Yan L., Ahmad S., Hansen M.B., Coquet J., Mustelin T., Koralov S.B. et al. The Journal of investigative dermatology. Peer-reviewed.

[DOI][Pmid][serval:BIB_96839F5A8257]

2024

Effect of betablockers on the course of Martorell hypertensive ulcers: a retrospective study.

Cleusix L., Pavlova O., Guenova E., Kuonen F., 2024/11/07. Acta dermato-venereologica, 104 pp. adv41087. Peer-reviewed.

[DOI][Pmid][serval:BIB_7E014843B639]

Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.

Chiricozzi A., Coscarella G., Puig L., Vender R., Yeung J., Carrascosa J.M., Piaserico S., Gisondi P., Lynde C., Ferreira P. et al., 2024/11. Journal of the European Academy of Dermatology and Venereology, 38 (11) pp. 2175-2185. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_3E85C936E7FE]

IL-9 sensitizes human Th2 cells to pro-inflammatory IL-18 signals in atopic dermatitis

Stefanie Schärli, Fabian Luther, Jeremy Di Domizio, Christina Hillig, Susanne Radonjic-Hoesli, Kathrin Thormann, Dagmar Simon, Amalie Thorsti Møller Rønnstad, Iben Frier Ruge, Fritz Blaine G. et al., 2024/11. Journal of Allergy and Clinical Immunology. Peer-reviewed.

[DOI][serval:BIB_A5B3D7B90349]

Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options.

Maronese C.A., Valenti M., Moltrasio C., Romagnuolo M., Ferrucci S.M., Gilliet M., Costanzo A., Marzano A.V., 2024/11. The Journal of investigative dermatology, 144 (11) pp. 2364-2376. Peer-reviewed.

[DOI][Pmid][serval:BIB_37D52048BB09]

Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group.

Elsayad K., Guenova E., Assaf C., Nicolay J.P., Trautinger F., Stadler R., Waldstein C., Boterberg T., Meijnders P., Kirova Y. et al., 2024/11. European journal of cancer, 212 p. 115064. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_59C5B7DF582A]

OLFM4 regulates the antimicrobial and DNA binding activity of neutrophil cationic proteins.

Vandenberghe-Dürr S., Gilliet M., Di Domizio J., 2024/10/22. Cell reports, 43 (10) p. 114863. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_5705156C2467]

COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.

Esposito M., Yerly L., Shukla P., Hermes V., Sella F., Balazs Z., Lattmann E., Tastanova A., Turko P., Lang R. et al., 2024/10/17. The British journal of dermatology, 191 (5) pp. 775-790. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_41ED2ED028E5]

Predictors of initiating biologics in the treatment of psoriasis.

Linnemann E., Nielsen M.L., Maul L.V., Richter C., Dommann I., Zink A., Schlapbach C., Yawalkar N., Conrad C., Cozzio A. et al., 2024/10. International journal of dermatology, 63 (10) pp. e231-e239. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6385660DD65E]

Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.

Gori N., Ippoliti E., Ferrucci S.M., Balato A., Ortoncelli M., Maurelli M., Galluzzo M., Munera Campos M., Seremet T., Di Nardo L. et al., 2024/10. Journal of the European Academy of Dermatology and Venereology, 38 (10) pp. e852-e854. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_E18B9E1FA9BB]

A single bout of resistance exercise triggers mitophagy, potentially involving the ejection of mitochondria in human skeletal muscle.

Díaz-Castro F., Tuñón-Suárez M., Rivera P., Botella J., Cancino J., Figueroa A.M., Gutiérrez J., Cantin C., Deldicque L., Zbinden-Foncea H. et al., 2024/09. Acta physiologica, 240 (9) pp. e14203. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B35E10FCF638]

Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients.

Melchers S., Roemer M., Albrecht J.D., Assaf C., von Gugelberg C., Guenova E., Klemke C.D., Moritz RKC, Schlaak M., Stadler R. et al., 2024/09. Experimental dermatology, 33 (9) pp. e15171. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0D74764CCDB9]

Extending Maintenance Dosing Intervals for Guselkumab in the Treatment of Patients With Psoriasis.

Blauvelt A., Conrad C., Noe M.H., 2024/09/01. JAMA dermatology, 160 (9) pp. 919-920. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_AE61778D518B]

Paradoxical Psoriasis: From its Many Faces to Possible Shared Therapeutic Targets.

Maronese C.A., Costanzo A., Gilliet M., Marzano A.V., 2024/09. The Journal of investigative dermatology, 144 (9) pp. 2084-2085. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8C7C292D8A78]

Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial.

Puig L., Costanzo A., de Jong EMGJ, Torres T., Warren R.B., Wapenaar R., Wegner S., Gorecki P., Gramiccia T., Jazra M. et al., 2024/09. Dermatology and therapy, 14 (9) pp. 2539-2558. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6662A036C71F]

Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type: A case series and review of the literature.

Winkler M., Albrecht J.D., Sauer C., Kordaß T., Guenova E., Livingstone E., Wobser M., Mitteldorf C., Géraud C., Nicolay J.P., 2024/09. The Journal of dermatology, 51 (9) pp. 1233-1239. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_565A788D2615]

Pandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infection.

Arkin L.M., Costa-da-Silva A.C., Frere J., Ng A., Sharma R., Moon J.J., Bussan H.E., Kim C.H., Javaid A., Steidl O.R. et al., 2024/08/16. iScience, 27 (8) p. 110525. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_35ACC551B253]

Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.

Mitsunaga K., Bagot M., Ram-Wolff C., Guenova E., von Gugelberg C., Hodak E., Amitay-Laish I., Papadavid E., Jonak C., Porkert S. et al., 2024/08/14. The British journal of dermatology, 191 (3) pp. 419-427. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7FA3BAF6F879]

Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert Network.

Wolf P., Ceovic R., Conrad C., Falkensteiner K., Graier T., Kołt-Kamińska M., Marovt M., Mateeva V., Maul J.T., Navarini A.A. et al., 2024/08. Journal of the European Academy of Dermatology and Venereology, 38 (8) pp. 1531-1542. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0FFDB4FEF9D6]

Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group.

Kempf W., Mitteldorf C., Cerroni L., Willemze R., Berti E., Guenova E., Scarisbrick J.J., Battistella M., 2024/08. Journal of the European Academy of Dermatology and Venereology, 38 (8) pp. 1491-1503. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B83175B8CF59]

Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo.

Mamaghani S., Penna R.R., Frei J., Wyss C., Mellett M., Look T., Weiss T., Guenova E., Kündig T.M., Lauchli S. et al., 2024/07/24. Cells, 13 (15). Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_42516D524C9F]

Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).

Blanchard M., Morren M.A., Busschots A.M., Hauben E., Alberti-Violetti S., Berti E., Avallone G., Tavoletti G., Panzone M., Quaglino P. et al., 2024/07/16. The British journal of dermatology, 191 (2) pp. 233-242. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_4B285B4FA583]

Targeting IL-1 controls refractory pityriasis rubra pilaris.

Schmauch E., Severin Y., Xing X., Mangold A., Conrad C., Johannsen P., Kahlenberg J.M., Mellett M., Navarini A., Nobbe S. et al., 2024/07/05. Science advances, 10 (27) pp. eado2365. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C2D3F8232AED]

Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.

Bozonnat A., Beylot-Barry M., Dereure O., D'Incan M., Quereux G., Guenova E., Perier-Muzet M., Dalle S., Grange F., Viguier M.A. et al., 2024/07. EClinicalMedicine, 73 p. 102679. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_AC5F8280DCB7]

Diagnosis and management of COVID toes in outpatients: a case report.

Pouxe M., Abdulkarim A., de Vallière S., Seremet T., Favrat B., Kokkinakis I., 2024/06/28. Journal of medical case reports, 18 (1) p. 307. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_EC15270ADD60]

Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).

Tzoumpa S., Ingen-Housz-Oro S., de Masson A., Pham-Ledard A., El Aarbaoui T., Dereure O., Quereux G., Faiz S., de Vicq de Cumptich M., Ram-Wolff C. et al., 2024/06/20. The British journal of dermatology, 191 (1) pp. 143-144. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_14C6A3C59476]

Cytokine-pathway blockers worsen mycosis fungoides masquerading as psoriasis.

Blanchard G., Bisig B., de Leval L., Hohl D., Guenova E., 2024/06. JAAD case reports, 48 pp. 98-102. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_1EE4642C1F75]

EUSCAP: A Euromelanoma project to investigate skin cancer risk factors in Europe.

Wunderlich K., Suppa M., Lipski J., Deworme V., Wambreuse A., Njimi H., White J., Gaide O., Euromelanoma Working Group, Gandini S. et al., 2024/06. Journal of the European Academy of Dermatology and Venereology, 38 (6) pp. e515-e517. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C10E35EE75E3]

Immunobiology of IL-26.

Gilliet M., Modlin R.L., 2024/06. The Journal of investigative dermatology, 144 (6) pp. 1217-1222. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B42FC1E8E78A]

Italian S3-Guideline on the treatment of Atopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).

Argenziano G., Cusano F., Corazza M., Amato S., Amerio P., Naldi L., Patruno C., Pigatto P.D., Quaglino P., Gisondi P. et al., 2024/06. Italian journal of dermatology and venereology, 159 (3) pp. 279-284. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_77ADA693A54C]

Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA).

[URN][DOI][WoS][Pmid][serval:BIB_616FCBA6BC3F]

Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).

[URN][DOI][Pmid][serval:BIB_05C83EFC979A]

Lésions cutanées liées au diabète : une problématique souvent sous-diagnostiquée [Diabetes-related skin lesions : a frequently underdiagnosed problem]

Walha H., Gaide O., Wojtusciszyn A., 2024/05/29. Revue medicale suisse, 20 (876) pp. 1063-1068. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_DBAC8C6C6D6A]

Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26.

Baldo A., Di Domizio J., Yatim A., Vandenberghe-Dürr S., Jenelten R., Fries A., Grizzetti L., Kuonen F., Paul C., Modlin R.L. et al., 2024/05/06. The Journal of experimental medicine, 221 (5). Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_F6D0EEF91DAC]

The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum.

Ishii M., Yamada T., Ishikawa K., Ichinose K., Monod M., Ohata S., 2024/05/02. Antimicrobial agents and chemotherapy, 68 (5) pp. e0160923. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_3C535BC5E8F8]

An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis.

Eyerich K., Krueger J., Stahle M., Schakel K., Conrad C., Armstrong A., Gniadecki R., Puig L., Scoble T., Williams N., 2024/05. Journal of the European Academy of Dermatology and Venereology, 38 (5) pp. e424-e427. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_250494FB338A]

Decoding the impact of primary cutaneous B-cell lymphomas on patients' well-being.

Bernard P., Guenova E., 2024/05. Journal of the European Academy of Dermatology and Venereology, 38 (5) pp. 794-795. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_50F6DF06816C]

Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma.

Joo V., Abdelhamid K., Noto A., Latifyan S., Martina F., Daoudlarian D., De Micheli R., Pruijm M., Peters S., Hullin R. et al., 2024/04/30. Nature communications, 15 (1) p. 3664. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_4D3A2A46F635]

Mosaic RASopathies concept: different skin lesions, same systemic manifestations?

Morren M.A., Fodstad H., Brems H., Bedoni N., Guenova E., Jacot-Guillarmod M., Busiah K., Giuliano F., Gilliet M., Atallah I., 2024/04/19. Journal of medical genetics, 61 (5) pp. 411-419. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_40C612FFCAF2]

Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.

Vadivel C.K., Willerslev-Olsen A., Namini MRJ, Zeng Z., Yan L., Danielsen M., Gluud M., Pallesen EMH, Wojewoda K., Osmancevic A. et al., 2024/04/11. Blood, 143 (15) pp. 1496-1512. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_3DF042FBAE8E]

Dermatophytes and skin dermatophytoses in Southeast Asia-First epidemiological survey from Cambodia.

Uhrlaß S., Mey S., Koch D., Mütze H., Krüger C., Monod M., Nenoff P., 2024/04. Mycoses, 67 (4) pp. e13718. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_445FD0B29C6B]

Dermobile: A cost-effective portable device for erythema evaluation.

Del Río-Sancho S., Alvarez Martinez D., Pünchera J., Guerrier S., Laubach H.J., 2024/04. Skin research and technology, 30 (4) pp. e13668. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_65D92E5B8829]

Predicting Psoriatic Arthritis in Psoriasis Patients - A Swiss Registry Study.

Nielsen M.L., Petersen T.C., Maul L.V., Thyssen J.P., Thomsen S.F., Wu J.J., Navarini A.A., Kündig T., Yawalkar N., Schlapbach C. et al., 2024/04. Journal of psoriasis and psoriatic arthritis, 9 (2) pp. 41-50. Peer-reviewed.

[DOI][Pmid][serval:BIB_C055CD3EF40D]

Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).

Verardi F., Maul L.V., Borsky K., Steinmann S., Rosset N., Pons H.O., Sorbe C., Yawalkar N., Micheroli R., Egeberg A. et al., 2024/04. Journal of the European Academy of Dermatology and Venereology, 38 (4) pp. 719-731. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A5BFB7D5A3CD]

Aspects physiopathologiques cliniques et thérapeutiques de la maladie de Darier [Clinical, therapeutic and pathophysiological aspects of Darier's disease]

Bernard P., Blanchard M., Morren M.A., Guenova E., 2024/03/27. Revue medicale suisse, 20 (867) pp. 659-663. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_B50E9268AF6F]

Dermatoses bulleuses auto-immunes chez les enfants [Autoimmune bullous diseases in children]

Bruschi L., Minisini F., Nidegger A., Dubois J., Iselin C., Chang Y.T., Guenova E., Morren M.A., 2024/03/27. Revue medicale suisse, 20 (867) pp. 638-647. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_69DDB0F35EC5]

Impact dermatologique du changement climatique.

Gilliet M., Boehncke W.H., 2024/03/27. Revue medicale suisse, 20 (867) pp. 619-620. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_96C473C65E5C]

Thérapie du psoriasis pédiatrique : présent et futur [Treatment of childhood psoriasis: present and future]

Messina F., Conrad C., Morren M.A., 2024/03/27. Revue medicale suisse, 20 (867) pp. 631-635. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_D7E8B3C848A3]

Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial.

Puig L., Costanzo A., de Jong EMGJ, Torres T., Warren R.B., Wapenaar R., Wegner S., Gorecki P., Gramiccia T., Jazra M. et al., 2024/03. American journal of clinical dermatology, 25 (2) pp. 315-325. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_ED60BAACD034]

Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol.

Kinj R., Gaide O., Jeanneret-Sozzi W., Dafni U., Viguet-Carrin S., Sagittario E., Kypriotou M., Chenal J., Duclos F., Hebeisen M. et al., 2024/03. Clinical and translational radiation oncology, 45 p. 100743. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_A13C0D7F4DC1]

Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials.

Egeberg A., Conrad C., Gorecki P., Wegner S., Buyze J., Acciarri L., Thaçi D., 2024/03. Dermatology and therapy, 14 (3) pp. 745-758. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_3774E7C2AE70]

Cross-Comparison of Inflammatory Skin Disease Transcriptomics Identifies PTEN as a Pathogenic Disease Classifier in Cutaneous Lupus Erythematosus.

Aevermann B.D., Di Domizio J., Olah P., Saidoune F., Armstrong J.M., Bachelez H., Barker J., Haniffa M., Julia V., Juul K. et al., 2024/02. The Journal of investigative dermatology, 144 (2) pp. 252-262.e4. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_7C4E37647B4E]

Ein Fall von papulöser akantholytischer Dyskeratose mit IL-23/TNF-α-dominantem Immunprofil [A case of papular acantholytic dyskeratosis with IL-23/TNF-α dominant immune profile].

Ettinger M., Burner T., Lackner A., Guenova E., Kimeswenger S., Hoetzenecker W., 2024/02. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 22 (2) pp. 274-277. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_EC2B0620E45E]

SARS-CoV-2-Induced Vasculitic Skin Lesions Are Associated with Massive Spike Protein Depositions in Autophagosomes.

Gawaz A., Schindler M., Hagelauer E., Blanchard G., Riel S., Vollert A., Gilliet M., Unterluggauer L., Stary G., Pospischil I. et al., 2024/02. The Journal of investigative dermatology, 144 (2) pp. 369-377.e4. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_D55972044341]

MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides.

Chang Y.T., Prompsy P., Kimeswenger S., Tsai Y.C., Ignatova D., Pavlova O., Iselin C., French L.E., Levesque M.P., Kuonen F. et al., 2024/01/25. Nature communications, 15 (1) p. 752. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_95FE005765C9]

A Child with a Lump in the Neck: A Quiz.

Van Gysel D., Janmohamed S.R., Locy H., Hohl D., De Smedt K., 2024/01/08. Acta dermato-venereologica, 104 pp. adv18485. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_CF29C0999DB9]

Cryoglobulinemic vasculitis triggered by Staphylococcus aureus endocarditis with chronic hepatitis C virus co-infection: a case report and literature review.

Reinberg C., Vingerhoets S., Pavlova O., Guenova E., Papadimitriou-Olivgeris M., Comte D., 2024. Frontiers in immunology, 15 p. 1385086. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0B6B4366346E]

Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences.

Geskin L.J., Angello J.T., Bagot M., Guenova E., Nikbakht N., Querfeld C., Scarisbrick J.J., 2024/01. Clinical lymphoma, myeloma & leukemia, 24 (1) pp. 40-47. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_4A1304F559F1]

Fast, bedside diagnosis of toxic epidermal necrolysis using ex vivo confocal laser scanning microscopy: A retrospective study.

Tonellotto L., Seremet T., Vernez M., Guenova E., Kuonen F., 2024/01. Journal of the European Academy of Dermatology and Venereology, 38 (1) pp. 182-185. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_09F30CE70C46]

Freedom from disease in plaque psoriasis: Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nurses.

van Ee I., Deprez E., Egeberg A., Conrad C., Corazza V., Donati L., Lambert J., Lăpădatu R., Meyer A., Paul C. et al., 2024/01. Journal of the European Academy of Dermatology and Venereology, 38 (1) pp. e16-e19. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_3AEA392299CF]

Old Sins Cast Long Shadows: News on Staphylococcus aureus in Cutaneous T Cell Lymphoma.

Guenova E., Ødum N., 2024/01. The Journal of investigative dermatology, 144 (1) pp. 8-10. Peer-reviewed.

[DOI][Pmid][serval:BIB_5F7862B8559A]

Positive Impact of UV Photography on Individual Sun Protection: A Swiss Feasibility Study.

Corre T., Zimmermann K., Gaide O., Vernez D., Bulliard J.L., 2024. International journal of public health, 69 p. 1607604. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_EAEBD69E5A6C]

Prurigo nodularis forecast: Light type 2 inflammation with high chances of fibrosis.

Conrad C., Schlapbach C., 2024/01. The Journal of allergy and clinical immunology, 153 (1) pp. 93-94. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4054C394C639]

2023

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma.

Ninosu N., Melchers S., Kappenstein M., Booken N., Hansen I., Blanchard M., Guenova E., Assaf C., Goerdt S., Nicolay J.P., 2023/12/27. Cancers, 16 (1) p. 141. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_636A9FF705F3]

Antifungal Resistance on the Rise.

Monod M., Blanchard G., Guenova E., 2023/12. The Journal of investigative dermatology, 143 (12) pp. 2332-2334. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B96EB72EBC63]

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.

Latzka J., Assaf C., Bagot M., Cozzio A., Dummer R., Guenova E., Gniadecki R., Hodak E., Jonak C., Klemke C.D. et al., 2023/12. European journal of cancer, 195 p. 113343. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_CC0D46B51475]

Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2.

Armstrong A., Eyerich K., Conrad C., Zhu Y., Yang Y.W., Miller M., You Y., Shen Y.K., Foley P., Griffiths CEM et al., 2023/12. Journal of the European Academy of Dermatology and Venereology, 37 (12) pp. e1375-e1379. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_ECDD80B202C8]

Skin hyperpigmentation index in melasma: A complementary method to classic scoring systems.

Heidemeyer K., Cazzaniga S., Feldmeyer L., Imstepf V., Adatto M., Lehmann M., Rammlmair A., Pelloni L., Seyed Jafari S.M., Bossart S., 2023/12. Journal of cosmetic dermatology, 22 (12) pp. 3405-3412. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_2EC543ACEF02]

Botanical Extract Coacillium for Management of Paediatric Atopic Dermatitis: A Case Report.

Spring P., 2023/11/21. Acta dermato-venereologica, 103 pp. adv13376. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_E7C95285FEAC]

Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets.

Ettinger M., Burner T., Sharma A., Chang Y.T., Lackner A., Prompsy P., Deli I.M., Traxler J., Wahl G., Altrichter S. et al., 2023/11/17. Nature communications, 14 (1) p. 7470. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_D062CF696E69]

Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae.

Yamada T., Maeda M., Nagai H., Salamin K., Chang Y-T, Guenova E., Feuermann M., Monod M., 2023/11/15. Antimicrobial agents and chemotherapy, 67 (11) pp. e0093323. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_E2FBBBDB640E]

NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5.

Gurri S., Siegenthaler B., Cangkrama M., Restivo G., Huber M., Saliba J., Dummer R., Blank V., Hohl D., Werner S., 2023/11/08. EMBO molecular medicine, 15 (11) pp. e17761. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_876B60FDD738]

First update of the living European guideline (EuroGuiDerm) on atopic eczema.

Wollenberg A., Kinberger M., Arents B., Aszodi N., Barbarot S., Bieber T., Brough H.A., Pinton P.C., Christen-Zaech S., Deleuran M. et al., 2023/11. Journal of the European Academy of Dermatology and Venereology, 37 (11) pp. e1283-e1287. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DE7C33D57C8F]

Histology-based classifier to distinguish early mycosis fungoides from atopic dermatitis.

Roenneberg S., Braun S.A., Garzorz-Stark N., Stark S.P., Muresan A.M., Schmidle P., Biedermann T., Guenova E., Eyerich K., 2023/11. Journal of the European Academy of Dermatology and Venereology, 37 (11) pp. 2284-2292. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_BFFB3400E2F1]

Rezidivierende Tinea corporis generalisata durch einen Terbinafin-resistenten Trichophyton-rubrum-Stamm : Langzeitbehandlung mit Super-Bioavailability-Itraconazol [Recurrent tinea corporis generalisata due to Terbinafine-resistant Trichophyton rubrum strain : Long-term treatment with super bioavailability itraconazole]

Nenoff P., Stahl M., Schaller M., Burmester A., Monod M., Ebert A., Uhrlaß S., 2023/11. Dermatologie, 74 (11) pp. 864-873. Peer-reviewed.

[DOI][Pmid][serval:BIB_70AE3D595622]

Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.

Kwatra S.G., Yosipovitch G., Legat F.J., Reich A., Paul C., Simon D., Naldi L., Lynde C., De Bruin-Weller M.S., Nahm W.K. et al., 2023/10/26. The New England journal of medicine, 389 (17) pp. 1579-1589. Peer-reviewed.

[DOI][Pmid][serval:BIB_0A637DD42145]

Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma.

Tsai Y.C., Schlaepfer T., Ignatova D., Chang Y.T., Valaperti A., Amarov B., Blanchard G., Pehr K., Vonow-Eisenring M., Urosevic-Maiwald M. et al., 2023/10/25. The British journal of dermatology, 189 (5) pp. 603-611. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_ACBD06166FA1]

It is not always chlorhexidine: Identification of benzoxonium chloride and lauramine oxide as culprit allergens in a popular antiseptic in Switzerland.

Wüthrich H., Yatim A., Di Lucca J., Walker A., Ventejou S., Morren M.A., Goossens A., Dendooven E., Aerts O., Gilliet M. et al., 2023/10. Contact dermatitis, 89 (4) pp. 284-289. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_859D5730752D]

Reliable and rapid identification of terbinafine resistance in dermatophytic nail and skin infections.

Blanchard G., Amarov B., Fratti M., Salamin K., Bontems O., Chang Y.T., Sabou A.M., Künzle N., Monod M., Guenova E., 2023/10. Journal of the European Academy of Dermatology and Venereology, 37 (10) pp. 2080-2089. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_67E2E4B27959]

Vorinostat for treatment-refractory bullous pemphigoid.

Blanchard G., Solly F., Basset V., Fontao L., Blanchard M., Guenova E., 2023/10. Journal of the European Academy of Dermatology and Venereology, 37 (10) pp. e1218-e1220. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_3C8F343C0DE9]

Activin A-Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer.

Pich-Bavastro C., Yerly L., Di Domizio J., Tissot-Renaud S., Gilliet M., Kuonen F., 2023/09/01. Clinical cancer research, 29 (17) pp. 3498-3513. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_ED6EC1F62C5D]

Ex vivo harmonic generation microscopy assessment in cutaneous T-cell lymphomas diagnosis

Pavlova Olesya, Ghosh Shayantani, Blanchard Gabriela, Chang Yun-Tsan, Kim Doyoung, Staedler Davide, Bonacina Luigi, Guenova Emmanuella, 2023/09., ORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 113008 dans European Journal of Cancer.

[DOI][WoS][serval:BIB_032885F6D81B]

HLA I shields tumor lymphocytes from NK cell-mediated elimination in the skin

Chang Yun-Tsan, Kimeswenger Susanne, Tsai Yi-Chien, Prompsy Pacome, Pavlova Olesya, Pascolo Steve, Hoetzenecker Wolfram, Guenova Emmanuella, 2023/09., EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 112992 dans European Journal of Cancer.

[DOI][WoS][serval:BIB_184D784D3AA1]

Leveraging deep learning to resolve skin lymphoma characteristics through highly multiplexed protein fluorescent imaging

Prompsy Pacome, 2023/09., EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 113043 dans European Journal of Cancer.

[DOI][WoS][serval:BIB_CF4BC5FC11F1]

Mechanism of action of chlormethine gel in mycosis fungoides.

Guenova E., Ortiz-Romero P.L., Poligone B., Querfeld C., 2023/09. Journal of the European Academy of Dermatology and Venereology, 37 (9) pp. 1739-1748. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_A3E2E9672062]

Mogamulizumab-induced colitis

Blanchard Maël, Blanchard Gabriela, Guenova Emmanuella, 2023/09., EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 113089 dans European Journal of Cancer.

[DOI][WoS][serval:BIB_321F0302C1C1]

Multi-omics cytokine screening reveals immunosuppressive microenvironment in cutaneous T-cell lymphoma

Tsai Yi-Chien, Chang Yun-Tsan, Blanchard Gabriela, Blanchard Maël, Prompsy Pacôme, Iselin Christoph, Hötzenecker Wolfram, Pascolo Steve, Guenova Emmanuella, 2023/09., EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 113045 dans European Journal of Cancer.

[DOI][WoS][serval:BIB_5817247F4277]

T cell receptor beta constant 1 as a potential marker to better assess T cell clonality in skin samples

Iselin Christoph, Prompsy Pacome, André Florine, Tsai Yi-Chien, Guenova Emmanuella, Chang Yun-Tsan, 2023/09., EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 113047 dans European Journal of Cancer.

[DOI][WoS][serval:BIB_977B2EE0CC15]

Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients.

Fallet B., Foglierini M., Porret R., Alcaraz-Serna A., Sauvage C., Jenelten R., Caplanusi T., Gilliet M., Perez L., Fenwick C. et al., 2023/08. The Journal of infection, 87 (2) pp. 111-119. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_9DA429039D3E]

O08 Using single-cell transcriptomics to characterize early mechanisms of psoriasis resolution

Francis Luc, McCluskey Daniel, Ganier Clarisse, Du-Harpur Xinyi, Baudry David, Dhami Pawan, Barker Jonathon, Smith Catherine, Capon Francesca, Mahil Satveer, 2023/07/07. pp. e7-e7 dans British Journal of Dermatology.

[DOI][WoS][serval:BIB_84B1363E4372]

O09 Dynamic impact of chronic inflammation on epidermal autophagy pathway

Uddin Nazia, Ostano Paola, Chiorino Giovanna, di Domizio Jeremy, Gilliet Michel, Philpott Mike, Hannen Rosalind, Bergamaschi Daniele, 2023/07/07. pp. e7-e8 dans British Journal of Dermatology.

[DOI][WoS][serval:BIB_663AE5C25AB6]

CD38 Targeting Holds Potential for the Treatment of Aggressive Refractory Cutaneous T-Cell Lymphomas.

Pavlova O., Tsai Y.C., Chang Y.T., Vonow Eisenring M., Guenova E., 2023/07. The Journal of investigative dermatology, 143 (7) pp. 1122-1126. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_589F94F08AFD]

Differentiation of IL-26+ TH17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis.

Fries A., Saidoune F., Kuonen F., Dupanloup I., Fournier N., Guerra de Souza A.C., Haniffa M., Ma F., Gudjonsson J.E., Roesner L. et al., 2023/06/30. Nature communications, 14 (1) p. 3878. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_F7440A1D7F03]

Eczéma professionnel : intérêt d’une approche de médecine du travail dans l’itinéraire clinique [Work-related contact dermatitis: interest of an occupational medicine approach in the clinical pathway]

Beysard B., Chiarini B., Caplanusi T., Regamey F., 2023/06/14. Revue medicale suisse, 19 (831) pp. 1197-1199. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_77347A421EB2]

Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis.

Ma F., Plazyo O., Billi A.C., Tsoi L.C., Xing X., Wasikowski R., Gharaee-Kermani M., Hile G., Jiang Y., Harms P.W. et al., 2023/06/12. Nature communications, 14 (1) p. 3455. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_5EF388533E43]

A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplex.

Vicino A., Cochet S., Pistocchi S., Conrad C., Ribi C., Du Pasquier R., Brouland J.P., Théaudin M., 2023/06. Journal of the peripheral nervous system, 28 (2) pp. 266-268. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0A5312D01C4F]

Nutritional and metabolic characteristics of critically ill patients admitted for severe toxidermia.

Karakus M., Pantet O., Charrière M., Favre D., Gaide O., Berger M.M., 2023/06. Clinical nutrition, 42 (6) pp. 859-868. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_B839A782FA89]

What is new about primary cutaneous B cell lymphomas.

Blanchard M., Hoetzenecker W., Blanchard G., Guenova E., 2023/06. Italian journal of dermatology and venereology, 158 (3) pp. 205-216. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D51D610CA068]

Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion.

Hodak E., Geskin L., Guenova E., Ortiz-Romero P.L., Willemze R., Zheng J., Cowan R., Foss F., Mangas C., Querfeld C., 2023/05. American journal of clinical dermatology, 24 (3) p. 493. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_09F55381218D]

Non-invasive imaging of agminated Spitz nevi with line-field confocal optical coherence tomography.

Del Río-Sancho S., Gallay C., Ventéjou S., Christen-Zaech S., 2023/05. Journal of the European Academy of Dermatology and Venereology, 37 (5) pp. e658-e659. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_1A18D77249B6]

Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study.

Iversen L., Conrad C., Eidsmo L., Costanzo A., Narbutt J., Pinter A., Kingo K., Rivera Diaz R., Kolbinger F., Nanna M. et al., 2023/05. Journal of the European Academy of Dermatology and Venereology, 37 (5) pp. 1004-1016. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_F44282E5D35A]

Projet SELPHUV : personnaliser la prévention solaire au moyen de la photographie UV

Zimmermann Kathrine, Corre Tanguy, Gaide Olivier, Mueller Christine, Pasche Myriam, Vernez David, Bulliard Jean-Luc, 2023/04/18. (347) 74 [Raisons de santé ; 347], Centre universitaire de médecine générale et santé publique (Unisanté).

[URN][DOI][serval:BIB_DDFAC1893DA9]

A plain language summary of what freedom from disease means to people with psoriasis according to doctors, nurses, and people with psoriasis.

Ee I.V., Deprez E., Egeberg A., Conrad C., Corazza V., Donati L., Lambert J., Lăpădatu R., Meyer A., Paul C. et al., 2023/04. Journal of comparative effectiveness research, 12 (4) pp. e220206. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_AEF9C795915D]

Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey.

Quaglino P., Scarisbrick J., Roccuzzo G., Abeldano A., Battistella M., McCormack C., Cowan R., Cozzio A., Cury-Martins J., Enz P. et al., 2023/04. Journal of the European Academy of Dermatology and Venereology, 37 (4) pp. 680-688. Peer-reviewed.

[DOI][Pmid][serval:BIB_D7537C17C209]

International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study.

Geskin L.J., Kwinta B.D., Garcia-Saleem T.J., Akilov O.E., Enz P.A., Guenova E., Ortiz-Romero P.L., Papadavid E., Quaglino P., Rozati S. et al., 2023/04. Journal of the American Academy of Dermatology, 88 (4) pp. 935-937. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_4542D8A5917F]

Dermatomyosite juvénile : le point de vue du dermatologue [Juvenile dermatomyositis, the dermatologist's point of view].

Minisini F., Gilliet M., Morren M.A., 2023/03/29. Revue medicale suisse, 19 (820) pp. 632-636. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_0228E22363F4]

Mpox (variole du singe) : l’œil du dermatologue [Mpox (Monkeypox): from a dermatologist's point of view]

Marchal O., Sottas C., Pastor D., Toutous Trellu L., Kaya G., Gaide O., 2023/03/29. Revue medicale suisse, 19 (820) pp. 614-617. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_7E643E696E27]

Parlons du prurit.

Boehncke W.H., Gilliet M., 2023/03/29. Revue medicale suisse, 19 (820) pp. 603-604. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_142445C72530]

Tinea capitis: actualité d’une pathologie ancienne [Tinea capitis: new insights into an old disease]

Blanchard M., Norrenberg S., Monod M., Morren M.A., Guenova E., 2023/03/29. Revue medicale suisse, 19 (820) pp. 618-623. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_23DFE7F57FEB]

Type I IFNs link skin-associated dysbiotic commensal bacteria to pathogenic inflammation and angiogenesis in rosacea.

Mylonas A., Hawerkamp H.C., Wang Y., Chen J., Messina F., Demaria O., Meller S., Homey B., Di Domizio J., Mazzolai L. et al., 2023/02/22. JCI insight, 8 (4) pp. e151846. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_5858E94898BB]

Survey on Dermatophytes Isolated from Animals in Switzerland in the Context of the Prevention of Zoonotic Dermatophytosis.

Fratti M., Bontems O., Salamin K., Guenova E., Monod M., 2023/02/14. Journal of fungi, 9 (2) p. 253. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_CA1DA1DAF463]

Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial.

Mrowietz U., Barker J., Conrad C., Jullien D., Gisondi P., Flower A., Reddy J., Paris M., Picard H., Jardon S. et al., 2023/02. Journal of the European Academy of Dermatology and Venereology, 37 (2) pp. 348-355. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_648946B8915D]

Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.

Thaçi D., Vender R., de Rie M.A., Conrad C., Pariser D.M., Strober B., Vanvoorden V., Wang M., Madden C., de Cuyper D. et al., 2023/01/23. The British journal of dermatology, 188 (1) pp. 22-31. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_4984B95B8B7E]

Clinical Reasoning: A 39-Year-Old Man With Asymmetric Distal Weakness and Loss of Sensitivity.

Loser V., Blanchard G., Guenova E., Théaudin M., Vicino A., 2023/01/10. Neurology, 100 (2) pp. 88-93. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_168DB9B36816]

Allergic contact dermatitis from a skin-calming cream containing hydroxyphenyl propamidobenzoic acid.

Blanchard G., Walker A., Dendooven E., Aerts O., Goossens A., Gilliet M., Seremet T., 2023/01. Contact dermatitis, 88 (1) pp. 68-70. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_439CAE98D3CF]

Allergic contact dermatitis from pentylene glycol in 'hypoallergenic' eye cosmetics.

Seremet T., Aerts O., Walker A., Wüthrich H., Dendooven E., Goossens A., Gilliet M., 2023/01. Contact dermatitis, 88 (1) pp. 73-75. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_96C66FD4AF0B]

Clinical evaluation of the efficacy of fractional radiofrequency for the treatment and reduction of stretch marks: A prospective study.

Adatto M., 2023/01. Journal of cosmetic dermatology, 22 (1) pp. 214-221. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_CC678C4DFDC4]

Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study.

Chiricozzi A., Ferrucci S.M., Di Nardo L., Gori N., Balato A., Ortoncelli M., Maurelli M., Galluzzo M., Munera Campos M., Seremet T. et al., 2023. Expert opinion on biological therapy, 23 (12) pp. 1307-1315. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5C65215DEC5B]

Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion.

Hodak E., Geskin L., Guenova E., Ortiz-Romero P.L., Willemze R., Zheng J., Cowan R., Foss F., Mangas C., Querfeld C., 2023/01. American journal of clinical dermatology, 24 (1) pp. 5-14. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_ACBF82B1C2A0]

2022

Addendum: Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma.

Schaller J., Hajjami H.M., Rusakiewicz S., Ioannidou K., Piazzon N., Miles A., Golshayan D., Gaide O., Hohl D., Speiser D.E. et al., 2022/12/06..

[DOI][Pmid][serval:BIB_714CA1B23F87]

Precision medicine approach in a rare case of autosomal recessive congenital ichthyosis.

Ettinger M., Burner T., Lackner A., Schoeftner L.C., Holzgruber J., Gruber R., Guenova E., Schuetz-Bergmayr M., Fischer T., Gratz I.K. et al., 2022/12. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 20 (12) pp. 1651-1653. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_70112FBC718C]

Präzisionsmedizinischer Ansatz bei einem seltenen Fall von autosomal rezessiver kongenitaler Ichthyose.

[DOI][Pmid][serval:BIB_0413C3B8D04C]

Une simple éruption cutanée?

Thorens Aline, Kokkinakis Ioannis, Bogiatzi Sofia, Favrat Bernard, Conrad Curdin, Seremet Teofila, 2022/11/23. Forum Médical Suisse ‒ Swiss Medical Forum, 22 (47). Peer-reviewed.

[URN][DOI][serval:BIB_2FD790560789]

Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5.

Tusup M., Cheng P.F., Picardi E., Raziunaite A., Dummer R., Levesque M.P., French L.E., Guenova E., Kundig T.M., Pascolo S., 2022/11/21..

[DOI][WoS][Pmid][serval:BIB_E656531F7E16]

Allergic contact dermatitis from pantolactone and dexpanthenol in wound healing creams.

Blanchard G., Kerre S., Walker A., Dendooven E., Aerts O., Goossens A., Gilliet M., Seremet T., 2022/11. Contact dermatitis, 87 (5) pp. 468-471. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_7759305A738C]

Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study.

Torres T., Puig L., Vender R., Yeung J., Carrascosa J.M., Piaserico S., Gisondi P., Lynde C., Ferreira P., Bastos P.M. et al., 2022/11. American journal of clinical dermatology, 23 (6) pp. 891-904. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8BD57CEC2813]

European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations.

Wollenberg A., Kinberger M., Arents B., Aszodi N., Avila Valle G., Barbarot S., Bieber T., Brough H.A., Calzavara Pinton P., Christen-Zäch S. et al., 2022/11. Journal of the European Academy of Dermatology and Venereology, 36 (11) pp. 1904-1926. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_5CE55F845CF2]

Granulomatous slack skin: clinical characteristics, prognosis and response to therapy. A study from the Cutaneous Lymphoma French Study Group.

Battesti G., Ram-Wolff C., Dobos G., Aubin F., Algros M.P., Guenova E., Joly P., Courville P., Mourah S., Cayuela J.M. et al., 2022/11. The British journal of dermatology, 187 (5) pp. 790-793. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_02DEF43FA5F1]

Noninvasive in vivo characterization of laser-induced microscopic treatment zones: A new standard procedure.

Del Río-Sancho S., Martinez D.A., Merat R., Christen-Zaech S., Laubach H., 2022/11. Lasers in surgery and medicine, 54 (9) pp. 1183-1185. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0D8514835059]

PTCH1 inactivation is sufficient to cause basaloid follicular hamartoma in paediatric Nevoid basal cell carcinoma syndrome.

Blanchard G., Yurchenko A.A., Pop O.T., Weibel L., Theiler M., Hauser V., Fraitag S., Guenova E., Flatz L., Nikolaev S.I. et al., 2022/11. Journal of the European Academy of Dermatology and Venereology, 36 (11) pp. e954-e956. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6DF7BA8D506C]

Inhibiteurs des Janus kinases : nouvelles perspectives pour la médecine de précision ? [Janus kinase inhibitors : new perspectives for precision medicine ?]

Tachet J., Dumusc A., Conrad C., Grandoni F., Chalandon Y., Ribi C., Buclin T., Girardin F., 2022/10/19. Revue medicale suisse, 18 (800) pp. 1979-1983. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_0D12F79D0C49]

Biomarkers of disease progression in people with psoriasis: a scoping review.

Ramessur R., Corbett M., Marshall D., Acencio M.L., Barbosa I.A., Dand N., Di Meglio P., Haddad S., Jensen AHM, Koopmann W. et al., 2022/10. The British journal of dermatology, 187 (4) pp. 481-493. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_F30819CCD63D]

Biomarkers of systemic treatment response in people with psoriasis: a scoping review.

Corbett M., Ramessur R., Marshall D., Acencio M.L., Ostaszewski M., Barbosa I.A., Dand N., Di Meglio P., Haddad S., Jensen AHM et al., 2022/10. The British journal of dermatology, 187 (4) pp. 494-506. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_AF0562FE3E3D]

Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.

Bisig B., Cairoli A., Gaide O., Somja J., Bregnard C., Gaulard P., Xerri L., Lefort K., Missiaglia E., Gilliet M. et al., 2022/10. Virchows Archiv, 481 (4) pp. 653-657. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_6CF9902CA42C]

Phaeohyphomycosis caused by Phialophora americana in a dog.

Martini F., Seehusen F., Krudewig C., Beckmann K.M., Favrot C., Fischer N.M., Guenova E., Rostaher A., 2022/10. Veterinary dermatology, 33 (5) pp. 446-449. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_E5CF46384B0C]

Secukinumab demonstrated sustained retention, effectiveness and safety in a real-world setting in patients with moderate-to-severe plaque psoriasis: long-term results from an interim analysis of the SERENA study.

Augustin M., Sator P.G., von Kiedrowski R., Conrad C., Rigopoulos D., Romanelli M., Ghislain P.D., Torres T., Ioannides D., Aassi M. et al., 2022/10. Journal of the European Academy of Dermatology and Venereology, 36 (10) pp. 1796-1804. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_C9B923938980]

Identification of Dermatophyte and Non-Dermatophyte Agents in Onychomycosis by PCR and DNA Sequencing-A Retrospective Comparison of Diagnostic Tools.

Pospischil I., Reinhardt C., Bontems O., Salamin K., Fratti M., Blanchard G., Chang Y.T., Wagner H., Hermann P., Monod M. et al., 2022/09/27. Journal of fungi, 8 (10) p. 1019. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_DB3D0D62930E]

Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma.

Gaide O., Herrera F.G., Jeanneret Sozzi W., Gonçalves Jorge P., Kinj R., Bailat C., Duclos F., Bochud F., Germond J.F., Gondré M. et al., 2022/09. Radiotherapy and oncology, 174 pp. 87-91. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_3BC621CB1990]

European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy.

Wollenberg A., Kinberger M., Arents B., Aszodi N., Avila Valle G., Barbarot S., Bieber T., Brough H.A., Calzavara Pinton P., Christen-Zäch S. et al., 2022/09. Journal of the European Academy of Dermatology and Venereology, 36 (9) pp. 1409-1431. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_E37300840AC5]

Ex vivo confocal microscopy for the intraoperative assessment of deep margins in giant basal cell carcinoma.

Kechrid N., Tonellotto L., Monnier S., Rossi S.A., Ulrich F., Kuonen F., 2022/09. JAAD case reports, 27 pp. 41-45. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_7ECC762C875F]

Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort.

Assan F., Husson B., Hegazy S., Seneschal J., Aubin F., Mahé E., Jullien D., Sbidian E., D'Incan M., Conrad C. et al., 2022/09. Journal of the European Academy of Dermatology and Venereology, 36 (9) pp. 1578-1583. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_1F752DFF9A44]

Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round Delphi survey among international experts.

Ziehfreund S., Tizek L., Hangel N., Fritzsche M.C., Weidinger S., Smith C., Bryce P.J., Greco D., van den Bogaard E.H., Flohr C. et al., 2022/09. Journal of the European Academy of Dermatology and Venereology, 36 (9) pp. 1467-1476. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_DE72A9DCD046]

Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer [Short telomere syndrome in adults: a rare entity that should be evoked]

Coukos A., Daccord C., Lazor R., Blum S., Naveiras O., Unger S., Vionnet J., Gaide O., Koutsokera A., Moschouri E. et al., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1606-1613. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_610156412D48]

Integrated multi-omics reveals cellular and molecular interactions governing the invasive niche of basal cell carcinoma.

Yerly L., Pich-Bavastro C., Di Domizio J., Wyss T., Tissot-Renaud S., Cangkrama M., Gilliet M., Werner S., Kuonen F., 2022/08/20. Nature communications, 13 (1) p. 4897. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_A792039350C9]

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.

Olsen E.A., Whittaker S., Willemze R., Pinter-Brown L., Foss F., Geskin L., Schwartz L., Horwitz S., Guitart J., Zic J. et al., 2022/08/04. Blood, 140 (5) pp. 419-437. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_727FFEC72880]

HaCaT cells as a model system to study primary cilia in keratinocytes.

Blanchard G., Pich C., Hohl D., 2022/08. Experimental dermatology, 31 (8) pp. 1276-1280. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_BCE43CC5960F]

The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.

Bartl J., Zanini M., Bernardi F., Forget A., Blümel L., Talbot J., Picard D., Qin N., Cancila G., Gao Q. et al., 2022/07/13. Nature communications, 13 (1) p. 4061. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_93213C10CC73]

Nonmelanocytic Lesions: Actinic Keratosis

Gaide Olivier, Rakosi Adèle, Kuonen François, 2022/07/08. pp. 102-107 dans Atlas of Dermoscopy chap. 6C, CRC Press.

[serval:BIB_249C11966D02]

The Fate of Epidermal Tight Junctions in the stratum corneum: Their Involvement in the Regulation of Desquamation and Phenotypic Expression of Certain Skin Conditions.

Haftek M., Oji V., Feldmeyer L., Hohl D., Hadj-Rabia S., Abdayem R., 2022/07/05. International journal of molecular sciences, 23 (13) p. 7486. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_8CBC5E3F9603]

Evaluation of neurodevelopmental symptoms in 10 cases of neonatal ichthyosis and sclerosing cholangitis syndrome.

Salik D., Hadj-Rabia S., Hohl D., Vahidnezhad H., Youssefian L., Rakosi A., Dangoisse C., Marangoni M., Vilain C., Smits G., 2022/07. Pediatric dermatology, 39 (4) pp. 590-593. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_40E5D9C7B398]

CD30+ Transformed Mycosis Fungoides Associated with Sweet-like Dermatosis

André Florine, Prins Christa, Gillet Michel, Guenova Emmanuella, Blanchard Gabriela, 2022/06/21. Acta Dermato-Venereologica, 102 pp. adv00739. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_903BF9F5F793]

Gene Amplification of CYP51B: a New Mechanism of Resistance to Azole Compounds in Trichophyton indotineae.

Yamada T., Yaguchi T., Maeda M., Alshahni M.M., Salamin K., Guenova E., Feuermann M., Monod M., 2022/06/21. Antimicrobial agents and chemotherapy, 66 (6) pp. e0005922. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_05785D0F47A2]

Ex vivo confocal microscopy for surgical margin assessment: A histology-compared study on 109 specimens.

Grizzetti L., Kuonen F., 2022/06. Skin health and disease, 2 (2) pp. e91. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_9FE5EA6A1A4D]

Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose - a single center experience.

Puxkandl V., Bangerl T., Hanfstingl K., Guenova E., Hoetzenecker W., Altrichter S., 2022/06. The World Allergy Organization journal, 15 (6) p. 100654. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_FAFDEA56B0C2]

TYK-ing all the boxes in psoriasis.

Schlapbach C., Conrad C., 2022/06. The Journal of allergy and clinical immunology, 149 (6) pp. 1936-1939. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F9865D08F780]

Birth of a Melanoma.

Bogiatzi S., Pagnoni A., Hohl D., Gaide O., 2022/05. Dermatology practical & conceptual, 12 (2) pp. e2022070. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_DCE1A64E6D68]

Chlormethin‐Gel zur Behandlung der Mycosis fungoides: Ein Expertenkonsens aus Deutschland, Österreich und der Schweiz (DACH‐Region) zum Therapiemanagement

Assaf Chalid, Booken Nina, Dippel Edgar, Guenova Emmanuella, Jonak Constanze, Klemke Claus-Detlev, Nicolay Jan P., Schlaak Max, Wobser Marion, Trautinger Franz, 2022/05. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 20 (5) pp. 579-588. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_B17FFCEC8611]

Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T‐cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop.

Kempf W., Petrella T., Willemze R., Jansen P., Berti E., Santucci M., Geissinger E., Cerroni L., Maubec E., Battistella M. et al., 2022/05. The British journal of dermatology, 186 (5) pp. 887-897. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FB2F05BF7238]

International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.

van Huizen A.M., Menting S.P., Gyulai R., Iversen L., van der Kraaij G.E., Middelkamp-Hup M.A., Warren R.B., Spuls P.I., SPIN MTX Consensus Survey Study Group, Schejtman A.A. et al., 2022/05/01. JAMA dermatology, 158 (5) pp. 561-572. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B539AD0B6ECF]

Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis.

Reich K., Conrad C., Kristensen L.E., Smith S.D., Puig L., Rich P., Sapin C., Holzkaemper T., Koppelhus U., Schuster C., 2022/05. The Journal of dermatological treatment, 33 (3) pp. 1652-1660. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_03FD28E40BB4]

The biological basis of disease recurrence in psoriasis: a historical perspective and current models.

Puig L., Costanzo A., Muñoz-Elías E.J., Jazra M., Wegner S., Paul C.F., Conrad C., 2022/05. The British journal of dermatology, 186 (5) pp. 773-781. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_9B5C6A3A10DD]

The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region).

Assaf C., Booken N., Dippel E., Guenova E., Jonak C., Klemke C.D., Nicolay J.P., Schlaak M., Wobser M., Trautinger F., 2022/05. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 20 (5) pp. 579-586. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9EDB11B33700]

Sphingolipids control dermal fibroblast heterogeneity.

Capolupo L., Khven I., Lederer A.R., Mazzeo L., Glousker G., Ho S., Russo F., Montoya J.P., Bhandari D.R., Bowman A.P. et al., 2022/04/15. Science, 376 (6590) pp. eabh1623. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D703E8F69887]

IgA Vasculitis With Henoch-Schönlein Purpura as an Immune Complication Associated With Left Ventricle Assist Device Insertion.

Ait-Tigrine S., Liaudet L., Bogiatzi S., Yerly P., Hullin R., Kirsch M., 2022/04/01. ASAIO journal, 68 (4) pp. e69-e72. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_7F60CAF4D34F]

Interleukin-17E, inducible nitric oxide synthase and arginase1 as new biomarkers in the identification of neutrophilic dermatoses.

Stalder R., Brembilla N., Conrad C., Yawalkar N., Navarini A., Boehncke W.H., Kaya G., 2022/04. Clinical and experimental dermatology, 47 (4) pp. 675-683. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_A648075F44ED]

Eczéma induit par les anti-IL-17 et le yin-yang Th2/Th17 [Anti-IL17 induced eczema and the yin-yang of Th2 and Th17]

Nidegger A., Jenelten R., Conrad C., 2022/03/30. Revue medicale suisse, 18 (775) pp. 574-577. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_A467263B846F]

La dermatologie à l’ère du Covid-19 []

Gilliet M., Boehncke W.H., 2022/03/30. Revue medicale suisse, 18 (775) pp. 571-572. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_5E960208BEC3]

Mycosis fongoïde et syndrome de Sézary : revue systématique [Mycosis fungoides and Sézary syndrome : a systematic review]

André F., Guenova E., Blanchard G., 2022/03/30. Revue medicale suisse, 18 (775) pp. 578-589. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_C5B73CBE2CDF]

Prise en charge des ulcères chroniques : la greffe en pastilles [Management of chronic ulcers: punch grafting]

Koulouri A., Buset C., Hafner J., Kuonen F., 2022/03/30. Revue medicale suisse, 18 (775) pp. 604-607. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_934C71379870]

An atypical presentation of borrelial lymphocytoma in 4 children.

Ventéjou S., Bourban-Jirounek C., Christen-Zaech S., Morren M.A., 2022/03. Annales de dermatologie et de venereologie, 149 (1) pp. 61-63. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D35713D3A331]

Freedom from disease in psoriasis: a Delphi consensus definition by patients, nurses and physicians.

van Ee I., Deprez E., Egeberg A., Augustin M., Conrad C., Corazza V., Donati L., Lambert J., Lăpădatu R., Meyer A. et al., 2022/03. Journal of the European Academy of Dermatology and Venereology, 36 (3) pp. 403-412. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_73AFCE8CCB66]

Ixekizumab and ustekinumab in psoriasis: post-hoc comparison of onset and duration of treatment response.

Radtke M., Conrad C., Schuster C., Saure D., Mert C., Riedl E., Costanzo A., 2022/03. The Journal of dermatological treatment, 33 (2) pp. 1168-1170. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_C9A7B7A0C724]

Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors.

Moret E., Ambresin A., Gianniou C., Bijon J., Besse-Hayat C., Bogiatzi S., Hohl D., Spertini F., Mantel I., 2022/03. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 260 (3) pp. 1005-1014. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_C16845CB364E]

Papillon-Lefevre syndrome treated by acitretin: case report and cytokine profile.

Leuenberger M., Fischer L., Mylonas A., Huber M., Di Domizio J., Gilliet M., Conrad C., Hohl D., 2022/03. Journal of the European Academy of Dermatology and Venereology, 36 (3) pp. e235-e238. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A3461686B46A]

The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.

Domizio J.D., Gulen M.F., Saidoune F., Thacker V.V., Yatim A., Sharma K., Nass T., Guenova E., Schaller M., Conrad C. et al., 2022/03. Nature, 603 (7899) pp. 145-151. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_EB150385781D]

Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment.

Jomrich G., Kollmann D., Ramazanova D., Ristl R., Grose R.P., Ilhan-Mutlu A., Preusser M., Fassnacht C., Tsai Y.C., Guenova E. et al., 2022/02. European journal of surgical oncology, 48 (2) pp. 383-390. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7C80EE8E129C]

Simultaneous Delivery of Econazole, Terbinafine and Amorolfine with Improved Cutaneous Bioavailability: A Novel Micelle-Based Antifungal "Tri-Therapy".

Gou S., Monod M., Salomon D., Kalia Y.N., 2022/01/24. Pharmaceutics, 14 (2) p. 271. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_85B3563E1E19]

Acrokeratosis Paraneoplastica (Bazex Syndrome): A Case Report.

Holzgruber J., Oberneder-Popper J., Guenova E., Hötzenecker W., 2022. Case reports in dermatology, 14 (3) pp. 307-312. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_32CB9BCC02C5]

Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions.

Chang Y.T., Ignatova D., Hoetzenecker W., Pascolo S., Fassnacht C., Guenova E., 2022/01. JID innovations, 2 (1) p. 100069. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_6E6C6BA75B7C]

Line-field confocal optical coherence tomography of pyogenic granulomas in children: report of two cases.

Gallay C., Ventéjou S., Christen-Zaech S., 2022/01. Journal of the European Academy of Dermatology and Venereology, 36 (1) pp. e37-e39. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5FED4FCE3441]

Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma.

Blanchard G., Guenova E., 2022/01. The British journal of dermatology, 186 (1) pp. 15-16. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4D238A090854]

Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis.

Conrad C., Ortmann C.E., Vandemeulebroecke M., Kasparek T., Reich K., 2022/01. Dermatology and therapy, 12 (1) pp. 233-241. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_A6C8705C68DD]

Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.

Querfeld C., Scarisbrick J.J., Assaf C., Guenova E., Bagot M., Ortiz-Romero P.L., Quaglino P., Bonizzoni E., Hodak E., 2022. Dermatology, 238 (2) pp. 347-357. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F7F93EFFBD12]

Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.

Zehnder M., Amarov B., Abrunhosa-Branquinho A.N., Maiwald-Urosevic M., Mühleisen B., Saulite I., Anzengruber F., Imhof L., Navarini A.A., Cozzio A. et al., 2022. Dermatology, 238 (5) pp. 967-976. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D6A98B53A31C]

Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study.

Klein T.M., Blome C., Kleyn C.E., Conrad C., Sator P.G., Ståhle M., Eyerich K., Radtke M.A., Bundy C., Cordey M. et al., 2022/01. Dermatology and therapy, 12 (1) pp. 81-95. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_77EA92840B70]

The A to I editing landscape in melanoma and its relation to clinical outcome.

Amweg A., Tusup M., Cheng P., Picardi E., Dummer R., Levesque M.P., French L.E., Guenova E., Läuchli S., Kundig T. et al., 2022/01. RNA biology, 19 (1) pp. 996-1006. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_31BF88A84F09]

2021

Trial of Spesolimab for Generalized Pustular Psoriasis.

Bachelez H., Choon S.E., Marrakchi S., Burden A.D., Tsai T.F., Morita A., Navarini A.A., Zheng M., Xu J., Turki H. et al., 2021/12/23. The New England journal of medicine, 385 (26) pp. 2431-2440. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_3270ED21E706]

A Closure Option for Combination Defects of the Nasal Sidewall and Paranasal Cheek.

Zahn C.A., Kuonen F., 2021/12/01. Dermatologic surgery, 47 (12) pp. 1626-1628. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_BDBF0AF79DF1]

Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study.

Maul J.T., Augustin M., Sorbe C., Conrad C., Anzengruber F., Mrowietz U., Reich K., French L.E., Radtke M., Häusermann P. et al., 2021/12. The British journal of dermatology, 185 (6) pp. 1160-1168. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_E3182B041A34]

Corrigendum to 'Outbreak of Trichophyton soudanense causing tinea capitis in an orphanage in Myanmar' [J Mycol Med 30 (2020) 101013].

Norrenberg S., Monod M., Christen-Zaech S., 2021/12. Journal de mycologie medicale, 31 (4) p. 101209. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A64AE72E6B19]

Autoexamen de la peau : de l’œil nu à l’optique du smartphone []

Postel-Vinay N., Baud D., Gaide O., 2021/11/10. Revue medicale suisse, 17 (758) pp. 1948-1951. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_BF0E575CCC68]

Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity.

Papadavid E., Kapniari E., Pappa V., Nikolaou V., Iliakis T., Dalamaga M., Jonak C., Porkert S., Engelina S., Quaglino P. et al., 2021/11. The British journal of dermatology, 185 (5) pp. 1035-1044. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_461B3C7D6937]

Mycosis fungoides-derived exosomes and their microRNA-1246 cargo: a message from the skin.

Pospischil I., Guenova E., 2021/11. The British journal of dermatology, 185 (5) pp. 884-886. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_6D3543B48142]

A weakly supervised deep learning approach for label-free imaging flow-cytometry-based blood diagnostics.

Otesteanu C.F., Ugrinic M., Holzner G., Chang Y.T., Fassnacht C., Guenova E., Stavrakis S., deMello A., Claassen M., 2021/10/25. Cell reports methods, 1 (6) p. 100094. Peer-reviewed.

[DOI][Pmid][serval:BIB_A62E636357DA]

c-FOS drives reversible basal to squamous cell carcinoma transition.

Kuonen F., Li N.Y., Haensel D., Patel T., Gaddam S., Yerly L., Rieger K., Aasi S., Oro A.E., 2021/10/05. Cell reports, 37 (1) p. 109774. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_F716EFFD62BE]

Granulomatous slack skin: clinical retrospective study of 8 cases of the Cutaneous Lymphoma French Study Group.

Battesti G., Ram-Wolff C., Dobos G., Aubin F., Algros M.P., Guenova E., Joly P., Courville P., Mourah S., Cayuela J.M. et al., 2021/10. European journal of cancer, 156 Suppl 1 pp. S35-S36. Peer-reviewed.

[DOI][Pmid][serval:BIB_EA033B0656AA]

HOPX Exhibits Oncogenic Activity during Squamous Skin Carcinogenesis.

Pavlova O., Lefort K., Mariotto A., Huber M., Hohl D., 2021/10. The Journal of investigative dermatology, 141 (10) pp. 2354-2368. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B4C1D733C899]

Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab.

Brunner P.M., Conrad C., Vender R., Grond S., Schuster C., Patel H., Xu W., Carrascosa Carrillo J.M., 2021/10. The British journal of dermatology, 185 (4) pp. 865-867. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_65744C0AFDC2]

Microvascular Skin Manifestations Caused by COVID-19.

Gawaz A., Guenova E., 2021/10. Hamostaseologie, 41 (5) pp. 387-396. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_57DEEAE4BBB2]

Mycosis fungoides and Sézary syndrome.

Jonak C., Tittes J., Brunner P.M., Guenova E., 2021/09. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 19 (9) pp. 1307-1334. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_4725444EC41C]

Méningite chronique : étiologies et approche diagnostique [Chronic meningitis: etiologies and diagnostic work-up]

Ammann S., Correia P., Di Virgilio G., Bally F., Maniu C.M., Garin N., Schmid R., 2021/09/01. Revue medicale suisse, 17 (748) pp. 1475-1480. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_51C9267A3403]

Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11

Contact
Annuaires

Informations légales
Plan du site
Edition